BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18687690)

  • 1. AML1/RUNX1 works as a negative regulator of c-Mpl in hematopoietic stem cells.
    Satoh Y; Matsumura I; Tanaka H; Ezoe S; Fukushima K; Tokunaga M; Yasumi M; Shibayama H; Mizuki M; Era T; Okuda T; Kanakura Y
    J Biol Chem; 2008 Oct; 283(44):30045-56. PubMed ID: 18687690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation.
    Heller PG; Glembotsky AC; Gandhi MJ; Cummings CL; Pirola CJ; Marta RF; Kornblihtt LI; Drachman JG; Molinas FC
    Blood; 2005 Jun; 105(12):4664-70. PubMed ID: 15741216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The thrombopoietin/MPL/Bcl-xL pathway is essential for survival and self-renewal in human preleukemia induced by AML1-ETO.
    Chou FS; Griesinger A; Wunderlich M; Lin S; Link KA; Shrestha M; Goyama S; Mizukawa B; Shen S; Marcucci G; Mulloy JC
    Blood; 2012 Jul; 120(4):709-19. PubMed ID: 22337712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation.
    Goncalves F; Lacout C; Villeval JL; Wendling F; Vainchenker W; Dumenil D
    Blood; 1997 May; 89(10):3544-53. PubMed ID: 9160659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AML1/Runx1 negatively regulates quiescent hematopoietic stem cells in adult hematopoiesis.
    Ichikawa M; Goyama S; Asai T; Kawazu M; Nakagawa M; Takeshita M; Chiba S; Ogawa S; Kurokawa M
    J Immunol; 2008 Apr; 180(7):4402-8. PubMed ID: 18354160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentiviral gene transfer regenerates hematopoietic stem cells in a mouse model for Mpl-deficient aplastic anemia.
    Heckl D; Wicke DC; Brugman MH; Meyer J; Schambach A; Büsche G; Ballmaier M; Baum C; Modlich U
    Blood; 2011 Apr; 117(14):3737-47. PubMed ID: 21289307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mpl receptor defect leads to earlier appearance of hematopoietic cells/hematopoietic stem cells in the Aorta-Gonad-Mesonephros region, with increased apoptosis.
    Fleury M; Petit-Cocault L; Clay D; Souyri M
    Int J Dev Biol; 2010; 54(6-7):1067-74. PubMed ID: 20711984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Top-down motif engineering of a cytokine receptor for directing ex vivo expansion of hematopoietic stem cells.
    Saka K; Kawahara M; Teng J; Otsu M; Nakauchi H; Nagamune T
    J Biotechnol; 2013 Dec; 168(4):659-65. PubMed ID: 24070902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embryonic stem cell differentiation to hematopoietic cells: A model to study the function of various regions of the intracytoplasmic domain of cytokine receptors in vitro.
    Filippi MD; Porteu F; Le Pesteur F; Rameau P; Nogueira MM; Debili N; Vainchenker W; de Sauvage FJ; Kupperschmitt AD; Sainteny F
    Exp Hematol; 2000 Dec; 28(12):1363-72. PubMed ID: 11146158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis.
    Lannutti BJ; Epp A; Roy J; Chen J; Josephson NC
    Blood; 2009 Feb; 113(8):1778-85. PubMed ID: 18796624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial protein C receptor supports hematopoietic stem cell engraftment and expansion in Mpl-deficient mice.
    Kohlscheen S; Schenk F; Rommel MGE; Cullmann K; Modlich U
    Blood; 2019 Mar; 133(13):1465-1478. PubMed ID: 30683655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y; Harada H
    J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells.
    Mulloy JC; Cammenga J; MacKenzie KL; Berguido FJ; Moore MA; Nimer SD
    Blood; 2002 Jan; 99(1):15-23. PubMed ID: 11756147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes.
    Tiedt R; Coers J; Ziegler S; Wiestner A; Hao-Shen H; Bornmann C; Schenkel J; Karakhanova S; de Sauvage FJ; Jackson CW; Skoda RC
    Blood; 2009 Feb; 113(8):1768-77. PubMed ID: 18845793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AML1/ETO trans-activates c-KIT expression through the long range interaction between promoter and intronic enhancer.
    Tian Y; Wang G; Hu Q; Xiao X; Chen S
    J Cell Biochem; 2018 Apr; 119(4):3706-3715. PubMed ID: 29236325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl.
    Alexander WS; Roberts AW; Nicola NA; Li R; Metcalf D
    Blood; 1996 Mar; 87(6):2162-70. PubMed ID: 8630375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin regulates IEX-1 gene expression through ERK-induced AML1 phosphorylation.
    Hamelin V; Letourneux C; Romeo PH; Porteu F; Gaudry M
    Blood; 2006 Apr; 107(8):3106-13. PubMed ID: 16368886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transcription factor PlagL2 activates Mpl transcription and signaling in hematopoietic progenitor and leukemia cells.
    Landrette SF; Madera D; He F; Castilla LH
    Leukemia; 2011 Apr; 25(4):655-62. PubMed ID: 21263445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation of Runx1 regulatory regions correlates with transition from primitive to definitive hematopoietic potential in vitro and in vivo.
    Webber BR; Iacovino M; Choi SH; Tolar J; Kyba M; Blazar BR
    Blood; 2013 Oct; 122(17):2978-86. PubMed ID: 24030384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs.
    Mandoli A; Singh AA; Prange KHM; Tijchon E; Oerlemans M; Dirks R; Ter Huurne M; Wierenga ATJ; Janssen-Megens EM; Berentsen K; Sharifi N; Kim B; Matarese F; Nguyen LN; Hubner NC; Rao NA; van den Akker E; Altucci L; Vellenga E; Stunnenberg HG; Martens JHA
    Cell Rep; 2016 Nov; 17(8):2087-2100. PubMed ID: 27851970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.